Such precision when targeting cancer cells with drugs is the holy grail in oncology. Antibodies can bind to cancer targets with laser-sharp specificity and stronger affinity compared to traditional small-molecule drugs. This allows them to precisely target and attack cancer cells while sparing healthy cells.
This innovative approach follows the revolutionary Nobel Prize-winning molecular technique called Phage Display, which is already up and running at the University of Malta. The team has already developed antibodies that specifically target the types of lung cancer.
Currently, these antibodies are being rigorously tested by the at the University of Malta. By teaming up with top scientists in the field from the University of Edinburgh, the University of Gdansk, and the University of Bari, the team is speeding up the development of these powerful cancer-fighting antibodies.
Join us on Tuesday 5 November 2024, at 19:00 at Studio B, Spazju Kreattiv, St James Cavalier, Valletta, for a fascinating talk by Prof. David Saliba on how these innovative technologies can help us in the fight against cancer. This will be followed by a discussion.
